Cargando…
Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
Since the introduction of PSA testing, significantly more men have been diagnosed and treated for prostate cancer. Localized prostate cancer typically is treated with prostatectomy, however there is still a high risk of recurrence after surgery, and adjuvant radiation has been shown to mitigate dise...
Autores principales: | Luo, Dong, Wang, Xinning, Zeng, Sophia, Ramamurthy, Gopalakrishnan, Burda, Clemens, Basilion, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764472/ https://www.ncbi.nlm.nih.gov/pubmed/31588336 http://dx.doi.org/10.1039/c9sc02290b |
Ejemplares similares
-
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021) -
Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis
por: Luo, Dong, et al.
Publicado: (2021) -
Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
por: Wang, Xinning, et al.
Publicado: (2021) -
A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer
por: Wang, Xinning, et al.
Publicado: (2022) -
Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
por: Wang, Xinning, et al.
Publicado: (2021)